Field defects in progression to gastrointestinal tract cancers

被引:51
作者
Bernstein, Carol [1 ,4 ]
Bernstein, Harris [1 ,3 ]
Payne, Claire M. [1 ,3 ]
Dvorak, Katerina [1 ,3 ,4 ]
Garewal, Harinder [2 ,3 ,4 ]
机构
[1] Univ Arizona, Coll Med, Dept Cell Biol & Anat, Tucson, AZ 85724 USA
[2] Univ Arizona, Dept Internal Med, Tucson, AZ 85724 USA
[3] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85724 USA
[4] Hematol Oncol So Arizona Vet Affairs Hlth Care Sy, Tucson, AZ 85723 USA
关键词
field of cancerization; field defect; gastrointestinal cancer; pre-malignant; cancer progression; tumorigenesis;
D O I
10.1016/j.canlet.2007.11.027
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
A field of defective tissue may represent a pre-malignant stage in progression to many cancers. However, field defects are often overlooked in studies of cancer progression through assuming tissue at some distance from the cancer is normal. We indicate, however, the generality of field defects in gastrointestinal cancers, including cancers of the oropharynx, esophagus, stomach, bile duct, pancreas, small intestine and colon/rectum. Common features of these field defects are reduced apoptosis competence, aberrant proliferation and genomic instability. These features are often associated with high bile acid exposure and may explain the association of dietary-related factors with cancer progression. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 71 条
[1]
Upregulated Akt signaling adjacent to gastric cancers: implications for screening and chemoprevention [J].
Ang, KL ;
Shi, DL ;
Keong, WW ;
Epstein, RJ .
CANCER LETTERS, 2005, 225 (01) :53-59
[2]
Severe imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomas [J].
Anti, M ;
Armuzzi, A ;
Morini, S ;
Iascone, E ;
Pignataro, G ;
Coco, C ;
Lorenzetti, R ;
Paolucci, M ;
Covino, M ;
Gasbarrini, A ;
Vecchio, FM ;
Gasbarrini, G .
GUT, 2001, 48 (02) :238-246
[3]
A "field change" of inhibited apoptosis occurs in colorectal mucosa adjacent to colorectal adenocarcinoma [J].
Badvie, S. ;
Hanna-Morris, A. ;
Andreyev, H. J. N. ;
Cohen, P. ;
Saini, S. ;
Allen-Mersh, T. G. .
JOURNAL OF CLINICAL PATHOLOGY, 2006, 59 (09) :942-946
[4]
Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? [J].
Baylin, SB ;
Ohm, JE .
NATURE REVIEWS CANCER, 2006, 6 (02) :107-116
[5]
Bernstein C, 1999, CANCER RES, V59, P2353
[6]
BERNSTEIN C, 2000, ELECT J BIOTECHNOL
[7]
Bile acids as carcinogens in human gastrointestinal cancers [J].
Bernstein, H ;
Bernstein, C ;
Payne, CM ;
Dvorakova, K ;
Garewal, H .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2005, 589 (01) :47-65
[8]
Unique dietary-related mouse model of colitis [J].
Bernstein, H ;
Holubec, H ;
Bernstein, C ;
Ignatenko, N ;
Gerner, E ;
Dvorak, K ;
Besselsen, D ;
Ramsey, L ;
Dall'Agnol, M ;
Blohm-Mangone, KA ;
Padilla-Torres, J ;
Cui, HY ;
Garewal, H ;
Payne, CM .
INFLAMMATORY BOWEL DISEASES, 2006, 12 (04) :278-293
[9]
Patchy field defects of apoptosis resistance and dedifferentiation in flat mucosa of colon resections from colon cancer patients [J].
Bernstein, H ;
Holubec, H ;
Warneke, JA ;
Garewal, H ;
Earnest, DL ;
Payne, CM ;
Roe, DJ ;
Cui, HY ;
Jacobson, EL ;
Bernstein, C .
ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (05) :505-517
[10]
p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus [J].
Bian, YS ;
Osterheld, MC ;
Bosman, FT ;
Benhattar, J ;
Fontolliet, C .
MODERN PATHOLOGY, 2001, 14 (05) :397-403